Ronald Vogel, PhD
Professor
Department:
Pharmacy
(520) 626-5730
E-mail:
Bio / Research:
Dr. Vogel's research program has focused on the economic and policy dimensions of the Medicare and Medicaid programs. He is also presently doing research on domestic and international pharmaceutical policy, with special emphasis upon pharmaceutical inputs into the health production function, parallel trade in pharmaceuticals, and the analytic aspects of future Medicare coverage of outpatient pharmaceuticals. In addition, he teaches Health Care Systems and Public Policy (PHSC 511), and Pharmaceutical Policy (PHSC 544).
Education:BA, University of Notre Dame, 1960
STB, University of Angers (France), 1962
MA, Marquette University, 1964
PhD, University of Wisconsin, 1967
Vogel RJ. Financing health care in sub-saharan africa. Westport and London: Greenwood Press 1993.
Vogel RJ. Crossing the border for health care: an exploratory study of consumer choice and financing mechanisms. Monograph No. 34. Southwest Border Rural Health Research Center. College of Medicine. University of Arizona 1993.
Vogel RJ. Health care cost recovery simulations from parametric estimates: methodology and results from Ogun state Nigeria. International Journal of Health Planning and Management 1994; 9: 183-198.
Vogel, RJ. Crossing the border for health care: an exploratory analysis of consumer choice. Journal of Borderlands Studies 1995; 10: 19-44.
Vogel RJ. Medicare managed care: budgetary and tax implications. Clinical Therapeutics 1998; 20: 1250-1262.
Vogel RJ. Medicare: issues in political economy. Ann Arbor :University of Michigan Press 1999.
Vogel RJ, Cox ER. Analytic dimensions of a prescription medication benefit in medicare. Clinical Therapeutics 2000; 22: 470-493.
Vogel RJ, Joish V. The potential unintended economic consequences of the medicine equity and drug safety act of 2000. Clinical Therapeutics 2001; 23: 629-643.
Vogel RJ. The basic economics of having and not having health insurance in the United States, chapter in H. Eng, editor, Health care coverage in Arizona (Tucson: Southwest Border Rural Health Research Center, January 2002).
Vogel RJ. The future outlook for Social Security, Medicare, and Medicaid, chapter in J. Hall, editor, The coming of age: A research report on aging, health and Arizona's capacity to care (Phoenix: St.Luke's Health Initiatives, June 2002).
Vogel RJ. The reasons behind rapidly rising pharmaceutical expenditures and the policy implications for the U.S. and Arizona, chapter in J. Hall, editor, The coming of age: a research report on aging, health and Arizona's capacity to care (Phoenix: St. Luke's Health Initiatives, June 2002).
Vogel RJ. Pharmaceutical patents and price controls. Clinical Therapeutics 2002; 24: 1204-1222..
Vogel RJ, Ramachandran S, Zachry W. A 3-Stage model for assessing the probable economic effects of direct to consumer advertising of pharmaceuticals. Clinical Therapeutics 2003; 25: 309-329.
Vogel RJ. Pharmaceutical pricing, price controls and their effects upon research and development expenditures in the european union. Clinical Therapeutics 2004; 26: 1327-1340. .
Shaw JW, Horrace WC, Vogel RJ. The determinants of life expectancy: An analysis of the OECD health data. Southern Economic Journal 2005; 71: 768-783.
Vogel RJ. Making the administration of the medicare program more efficient. Public Finance Review. Forthcoming.